Cell Culture Market Growth Forecast at 10.5% CAGR to 2020

Mar 02, 2016, 05:00 ET from ReportsnReports

PUNE, India, March 2, 2016 /PRNewswire/ --

Global cell culture market is projected to reach $18,630.7 million by 2020 from $11,310.9 million in 2015, at a CAGR of 10.5% and this report categorizes the market on basis of products, applications, end users, and regions.

Complete report on cell culture market spread across 264 pages, profiling 10 companies and supported with 232 tables and 57 figures is now available at http://www.reportsnreports.com/reports/291293-cell-culture-market-by-equipment-bioreactor-incubator-centrifuge-by-reagent-media-sera-growth-factors-serum-free-media-by-application-cancer-research-gene-therapy-drug-development-vaccine-production-toxicity-testing-global-forecast-to-2018.html   

Major factors contributing to the growth of the global cell culture market include the increasing incidence of chronic diseases, growth in number of regulatory approvals for cell culture-based vaccines, growing demand for mAbs, funding for cell-based research, rising adoption of single-use technologies, and technological advancements in cell culture products. However, factors such as high cost of research in cell biology and lack of infrastructure for cell-based research are likely to hinder the growth of this market during the forecast period.

The cell culture market in Asia is expected to witness the highest growth rate from 2015-2020. Emerging economies such as China and India preferred destinations for major pharmaceutical giants as the cost of production is significantly lower compared to developed nations. Moreover, regulatory norms in these countries are less stringent and the cost of labor is less. This in turn reduces the cost of production of biologics. Owing to these benefits, various pharmaceutical giants are actively investing in these markets to develop biopharmaceutical drugs. For instance, in June 2013, Boehringer Ingelheim (Germany) invested €35 million (USD 46.4 million) to establish a cGMP biopharmaceutical manufacturing facility in China.

Apart from the comprehensive regional analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. The company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, and change in strategic approach, R&D investments, and levels of output in order to remain successful.

The leading players in the cell culture industry include Thermo Fisher Scientific, Inc., Merck KGAA, Sigma Aldrich, GE Healthcare (A Subsidiary of General Electric Company), Lonza Group AG, Corning, Inc., Becton, Dickinson and Company, Eppendorf AG, Hi-Media Laboratories, Sartorius AG and Promocell GmbH. Order a copy of Cell Culture Market by Equipment (Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)), Consumables (FBS, ABS, Media, Reagents), Application (Therapeutics, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020 research report at http://www.reportsnreports.com/purchase.aspx?name=291293 .

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

On a related note, another research on Cell Analysis Market Forecast to 2020 says, the global cell analysis market is expected to reach USD 26.0 billion by 2020 from USD 19.0 billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020. In Asia-Pacific region, qPCR  and single cell analysis are expected to serve as new revenue pockets for the cell analysis market in the coming five years. Companies like Becton, Dickinson and Company, Merck KGAA, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Agilent Technologies, Inc., Olympus Corporation, Perkinelmer, Inc., Promega Corporation and Tecan Group Ltd. have been profiled in this 277 pages research report available at http://www.reportsnreports.com/reports/280776-cell-analysis-market-by-instruments-flow-cytometer-microscope-microfluidics-qpcr-consumables-application-cell-identification-cell-viability-cell-proliferation-cytology-signal-transduction-single-cell-analysis-global-forecast-to-2018.html .

Explore more reports on Biotechnology market at http://www.reportsnreports.com/market-research/biotechnology/ .

About Us:   

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Connect With Us on:  

Facebook: https://www.facebook.com/ReportsnReports/

LinkedIn: https://www.linkedin.com/company/reportsnreports

Twitter: https://twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts


Priyank Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+1 888 391 5441

SOURCE ReportsnReports